Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
Anton PottegårdFranziska HopfnerMette WodGünter U HöglingerMorten BlaabjergThomas W RöslerGregor KuhlenbäumerKaare ChristensenGünther DeuschlPublished in: Neurology (2020)